- Influenza activity increased nationally during week 13, with the central and south-central regions of the country experiencing the highest activity.
- The majority of influenza viruses detected are Influenza A(H3N2), and the H3N2 viruses are genetically closely related to the vaccine virus but have some antigenic differences.
- Outpatient visits for respiratory illness (ILI) accounted for 1.9% of patient visits, below the national baseline.
- Multiple respiratory viruses are co-circulating, and the contribution of influenza to respiratory illness varies by location.
- Influenza-associated hospitalizations have increased, with a cumulative hospitalization rate of 8.0 per 100,000 population.
- Pneumonia, influenza, and COVID-19 (PIC) mortality for week 13 was above the epidemic threshold, with 7.5% of deaths attributed to PIC.
- Two influenza-associated pediatric deaths were reported during week 13, bringing the total to 16 for the season.
- There are ongoing efforts to monitor antiviral susceptibility and vaccine effectiveness against circulating influenza viruses.
- CDC recommends annual influenza vaccination as the best way to protect against influenza and its complications.
- Additional surveillance information is available from national and international sources such as WHO and participating countries' health agencies.